Tumor Biology

, Volume 36, Issue 5, pp 3309–3317 | Cite as

Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing

Research Article


Cervical cancer is the third most common cancer and the fourth leading cause of cancer deaths among women in the world. The discovery of vital diagnostic and therapeutic markers against cervical squamous cell carcinoma (CSCC) would broaden our understanding on the molecular basis of CSCC. In this study, we thoroughly analyzed the transcriptome of CSCC and matched adjacent nontumor (ATN) tissue. RNA sequencing was performed to screen the differentially expressed genes (DEGs) of three pairs of CSCC and ATN tissues. Functional enrichment analysis was used to uncover the biological functions of DEGs. Protein interaction network was carried out to reveal interaction of DEGs. Quantitative real-time PCR was conducted to validate the expression of DEGs. Immunohistochemistry was used to detect the relationship between clinicopathological parameters of CSCC and DEGs. There were a total of 347 significantly common DEGs in the three paired examples, including 104 consistent upregulated and 148 consistent downregulated DEGs. The 347 DEGs were categorized into 73 functional categories by Gene Ontology (GO) analysis. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis suggested six significantly signal pathways. The protein interaction network uncovered three important DEGs, including retinol dehydrogenase 12 (RDH12), ubiquitin D (UBD), and serum amyloid A1 (SAA1). We found that RDH12 expression was decreased in 74.5 % of CSCC tissues. RDH12 expression was negatively associated with tumor size and depth of cervical invasion. The UBD was overexpressed in 61.7 % of CSCC tissues and was positively related with tumor size and lymphatic metastasis. The SAA1 protein was overexpressed in 57.4 % of CSCC tissues and was positively related with clinicopathological parameters of tumor size, lymphatic metastasis, and depth of cervical invasion. The RDH12, UBD, and SAA1 genes might participate in the progression of CSCC.


Cervical squamous cell carcinoma Adjacent nontumor tissues Transcriptome Differentially expressed genes RNA sequencing 



This research is supported by the National Natural Science Foundation of China (81472446).

Conflicts of interest


Supplementary material

13277_2014_2963_MOESM1_ESM.xls (228 kb)
S1 The list of differentially expressed genes. (XLS 227 kb)
13277_2014_2963_MOESM2_ESM.xls (83 kb)
S2 The list of functional categories of differentially expressed genes. (XLS 83 kb)
13277_2014_2963_Fig5_ESM.gif (2.9 mb)

Protein-protein interaction network construction of CSCC. The 13 cervical cancer related genes from NCI are filled with blue. Three novel cervical cancer related genes identified in our study are filled with red. The other detected DEGs in the PPI network are filled with green. Each link between two nodes corresponds to a direct interaction between the two genes according to HPRD database (GIF 2948 kb)

13277_2014_2963_MOESM3_ESM.tif (3.9 mb)
High resolution image (TIFF 3982 kb)


  1. 1.
    Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix-worldwide. Asian Pac J Cancer Prev. 2009;10:645–50.PubMedGoogle Scholar
  3. 3.
    McLaughlin-Drubin ME, Meyers J, Munger K. Cancer associated human papil-lomaviruses. Curr Opin Virol. 2012;2:459–66.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10:550–60.CrossRefPubMedGoogle Scholar
  5. 5.
    Grabowska AK, Riemer AB. The invisible enemy—how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J. 2012;6:249–56.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, ALTS. Group. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis. 2007;195:1582–9.CrossRefPubMedGoogle Scholar
  7. 7.
    de Freitas AC, Coimbra EC, Leitão MD. Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis. Biochim Biophys Acta. 1845;2014:91–103.Google Scholar
  8. 8.
    Wang YL, Ding XP, Xiong ZR, Liao H. Differential gene expression profile in cervical cancer and parenchyma infected with human papillomavirus 16 screened by cDNA microarray. Eur J Gynaecol Oncol. 2013;34:132–7.PubMedGoogle Scholar
  9. 9.
    Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy-analysis of affymetrix genechip data at the probe level. Bioinformatics. 2004;20:307–15.CrossRefPubMedGoogle Scholar
  10. 10.
    Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008;18:1509–17.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Zhang XM, Ma ZW, Wang Q, Wang JN, Yang JW, Li XD, et al. A new RNA-seq method to detect the transcription and non-codingRNA in prostate cancer. Pathol Oncol Res. 2014;20(1):43–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Wu Y, Wang X, Wu F, Huang R, Xue F, Liang G, et al. Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing. PLoS One. 2012;7:e41001.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Stephens PJ, Tarpey PS, Davies H, Von Loo P, Greenman C, Wedge DC, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012;486:400–4.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwa G, van Baren MJ, et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and inform switching during cell differentiation. Nat Biotechnol. 2010;28:511–5.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Zhang W, Edwards A, Fan W, Fang Z, Deininger P, Zhang K. Inferring the expression variability of human transposable element-derived exons by linear model analysis of deep RNA sequencing data. BMC Genomics. 2013;14:584.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.CrossRefGoogle Scholar
  17. 17.
    Morimoto I, Sasaki Y, Ishida S, Imai K, Tokino T. Identification of the osteopontin gene as a direct target of TP53. Genes Chromosome Cancer. 2002;33:270–8.CrossRefGoogle Scholar
  18. 18.
    Wong YF, Cheung TH, Tsao GS, Lo KW, Yim SF, Wang VW, et al. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer. 2006;118:2461–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Peng X, Wu Z, Yu L, Li J, Xu W, Chan HC, et al. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with humancervical cancer malignancy, progression and prognosis. Gynecol Oncol. 2012;125:470–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Lee J, Yoon YS, Chung JH. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines. Gynecol Oncol. 2008;109:270–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Yamaki M, Sugiura K, Muro Y, Shimoyama Y, Tomita Y. Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes. Exp Dermatol. 2010;19:730–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate. 2007;67:61–73.CrossRefPubMedGoogle Scholar
  23. 23.
    Eke I, Koch U, Hehlgans S, Sandfort V, Stanchi F, Zips D, et al. PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha. J Clin Invest. 2010;120:2516–27.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Ahmed KM, Zhang H, Park CC. NF-κB Regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells. Cancer Res. 2013;73:3737–48.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Ou J, Luan W, Deng J, Sa R, Liang H. αV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK/JNK pathway. PLoS One. 2012;7:e38737.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Zhou SL, Dai Z, Zhou ZJ, Chen Q, Wang Z, Xiao YS, et al. CXCL5 contributes to tumour metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoural neutrophils. Carcinogenesis. 2014;35:597–605.CrossRefPubMedGoogle Scholar
  27. 27.
    Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Buson TB, Chin A, et al. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression. Cancer Res. 2011;71:5090–100.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Kang JU, Koo SH, Kwon KC, Park JW, Kim JM. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer. 2009;9:237.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Liu YS, Luo XY, Li QR, Li H, Li C, Ni H, et al. Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA, and C4BP may refine prognosis of resected squamous cell lung cancer. J Mol Cell Biol. 2012;4:344–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Samarut E, Rochette-Egly C. Nuclear retinoic acid receptors: conductors of the retinoic acid symphony during development. Mol Cell Endocrinol. 2012;3488:348–60.CrossRefGoogle Scholar
  31. 31.
    Skrypnyk N, Chen X, Hu W, Su Y, Mont S, Yang S, et al. PPARα activation can help prevent and treat non-small cell lung cancer. Cancer Res. 2014;74:621–31.CrossRefPubMedGoogle Scholar
  32. 32.
    Su TR, Lin JJ, Tsai CC, Huang TK, Yang ZY, Wu MO, et al. Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells. Int J Mol Sci. 2013;14:20443–58.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem. 2000;267:4315–24.CrossRefPubMedGoogle Scholar
  34. 34.
    de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature. 1990;347:558–61.CrossRefPubMedGoogle Scholar
  35. 35.
    Kropotova ES, Zinov’eva OL, Zyrianova AF, Choĭnzonov EL, Afanas’ev SG, Cherdyntseva NV, et al. Expression of genes involved in retinoic acid biosynthesis in human gastric cancer. Mol Biol. 2013;47:317–30.CrossRefGoogle Scholar
  36. 36.
    Chen J, Yang L, Chen H, Yuan T, Liu M, Chen P. Recombinat adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo. Exp Mol Pathol. 2014;96:207–11.CrossRefPubMedGoogle Scholar
  37. 37.
    Gao Y, Theng SS, Zhuo J, Teo WB, Ren J, Lee CG. FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells. Carcinogenesis. 2014;35:923–34.CrossRefPubMedGoogle Scholar
  38. 38.
    Olsen HG, Skovgaard K, Nielsen OL, Leifsson PS, Jensen HE, Lburg T, et al. Organization and biology of the porcine serum amyloid A (SAA) gene cluster: isoform specific responses to bacterial infection. PLoS One. 2013;8:e76695.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;9:501–23.CrossRefGoogle Scholar
  40. 40.
    Lu SY, Rodriguez M, Liao WS. YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-kappa B during acute-phase response. Mol Cell Biol. 1994;9:6523–63.Google Scholar
  41. 41.
    Furlaneto CJ, Campa A. A novel function of serum amyloid a: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun. 2000;9:405–8.CrossRefGoogle Scholar
  42. 42.
    Connolly M, Marrelli A, Blades M, McCormick J, Maderna P, Godson C, et al. Acute serum amyloid a induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol. 2010;9:6427–37.CrossRefGoogle Scholar
  43. 43.
    Lee HY, Kim MK, Park KS, Bae YH, Yun J, Park JI, et al. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem Biophys Res Commun. 2005;9:989–98.CrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyPeking Union Medical College HospitalBeijingPeople’s Republic of China
  2. 2.CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of MicrobiologyChinese Academy of SciencesBeijingPeople’s Republic of China

Personalised recommendations